Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Method Development and Validation for the Determination of Linezolid Drug in Human Plasma by Reversed-Phase High-Performance Liquid Chromatography

Author(s): Amina Missoum*, Kahina Hamza, Fatiha Malki, Abderrezak Hamdi and Hassan Y. Aboul-Enein*

Volume 18, Issue 5, 2022

Published on: 23 August, 2021

Page: [528 - 534] Pages: 7

DOI: 10.2174/1573412917666210823092454

Price: $65

conference banner
Abstract

Objective: Linezolid is a significant antibiotic used against severe infections initiated by multi-resistant bacterial pathogens.

Aims: The aim of this study is to develop and validate a simple, selective and accurate highperformance liquid chromatographic HPLC method for the analysis of linezolid LZD.

Methods: Linezolid extraction from plasma is obtained using methanol. Chromatographic separation is achieved isocratically on a C18 column [Zorbax C18, 5 μm particle size, 150 mm* 4.6 mm] making use of a mobile phase of acetonitrile / 0.05 M phosphate buffer, pH = 4.5 (30: 70 v/v) at a flow rate of 1.2 mL/min with photodiode array detector DAD, at a wavelength of 256 nm.

Results: The retention time of linezolid was 2.5 min. The analytical method was linear (r2 > 0.998) over the calibration range of 0.30 to 50.0 μg/mL. The extraction recoveries of linezolid range from 71.03 to 91.93 %. The limit of quantification and the limit of detection were 0.112 μg and 0.037 μg, respectively. The RSDs for intraday and interday assays were < 7.77 and 4.32 %, respectively. The intraday and interday accuracies were in the range 80.6-112 % and 77.44- 104.85 %, respectively.

Conclusion: The applied method is precise, accurate and appropriate for pharmacokinetic studies and therapeutic drug monitoring of linezolid in routine clinical practice.

Keywords: RP-HPLC, validation, Linezolid, human plasma, biomedical analysis, method development.

« Previous Next »
Graphical Abstract

[1]
Zurenko, G.E.; Yagi, B.H.; Schaadt, R.D.; Allison, J.W.; Kilburn, J.O.; Glickman, S.E.; Hutchinson, D.K.; Barbachyn, M.R.; Brickner, S.J. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother., 1996, 40(4), 839-845.
[http://dx.doi.org/10.1128/AAC.40.4.839] [PMID: 8849237]
[2]
Brickner, S.J.; Barbachyn, M.R.; Hutchinson, D.K.; Manninen, P.R. Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. J. Med. Chem., 2008, 51(7), 1981-1990.
[http://dx.doi.org/10.1021/jm800038g] [PMID: 18338841]
[3]
Rivera, A.M.; Boucher, H.W. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin. Proc., 2011, 86(12), 1230-1243.
[http://dx.doi.org/10.4065/mcp.2011.0514] [PMID: 22134942]
[4]
Biedenbach, D.J.; Jones, R.N. In vitro activity of linezolid (U-100766) against Haemophilus influenzae measured by three different susceptibility testing methods. Diagn. Microbiol. Infect. Dis., 2001, 39(1), 49-53.
[http://dx.doi.org/10.1016/S0732-8893(00)00210-8] [PMID: 11173191]
[5]
Zurenko, G.E.; Gibson, J.K.; Shinabarger, D.L.; Aristoff, P.A.; Ford, C.W.; Tarpley, W.G. Oxazolidinones: a new class of antibacterials. Curr. Opin. Pharmacol., 2001, 1(5), 470-476.
[http://dx.doi.org/10.1016/S1471-4892(01)00082-0] [PMID: 11764772]
[6]
Diekema, D.I.; Jones, R.N.; Oxaxolidinones, A. Oxazolidinones: a review. Drugs, 2000, 59(1), 7-16.
[http://dx.doi.org/10.2165/00003495-200059010-00002] [PMID: 10718097]
[7]
Diekema, D.J.; Jones, R.N. Oxazolidinone antibiotics. Lancet, 2001, 358(9297), 1975-1982.
[http://dx.doi.org/10.1016/S0140-6736(01)06964-1] [PMID: 11747939]
[8]
Vinh, D.C.; Rubinstein, E. Linezolid: a review of safety and tolerability. J. Infect., 2009, 59, S59-S74.
[http://dx.doi.org/10.1016/S0163-4453(09)60009-8] [PMID: 19766891]
[9]
Dong, H.; Wang, X.; Dong, Y.; Lei, J.; Li, H.; You, H.; Wang, M.; Xing, J.; Sun, J.; Zhu, H. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients. Int. J. Antimicrob. Agents, 2011, 38(4), 296-300.
[http://dx.doi.org/10.1016/j.ijantimicag.2011.05.007] [PMID: 21741222]
[10]
la Marca, G.; Villanelli, F.; Malvagia, S.; Ombrone, D.; Funghini, S.; De Gaudio, M.; Fallani, S.; Cassetta, M.I.; Novelli, A.; Chiappini, E.; de Martino, M.; Galli, L. Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot. J. Pharm. Biomed. Anal., 2012, 67-68(68), 86-91.
[http://dx.doi.org/10.1016/j.jpba.2012.04.007] [PMID: 22559989]
[11]
Siddiqui, M.R.; AlOthman, Z.A.; Rahman, N. Analytical techniques in pharmaceutical analysis. Arab. J. Chem., 2017, 10, S1409-S1421.
[http://dx.doi.org/10.1016/j.arabjc.2013.04.016]
[12]
Alothman, Z.A.; Rahman, N.; Siddiqui, M.R. Review on pharmaceutical impurities, stability studies and degradation products: an analytical approach. Rev. Adv. Sci. Eng., 2013, 2, 155-166.
[http://dx.doi.org/10.1166/rase.2013.1039]
[13]
Rahman, N.; Azmi, S.N.H.; Wu, H.F. The importance of impurity analysis in pharmaceutical products: an integrated approach. Accredit. Qual. Assur., 2006, 11, 69-74.
[http://dx.doi.org/10.1007/s00769-006-0095-y]
[14]
Baietto, L.; D’Avolio, A.; De Rosa, F.G.; Garazzino, S.; Patanella, S.; Siccardi, M.; Sciandra, M.; Di Perri, G. Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. Ther. Drug Monit., 2009, 31(1), 104-109.
[http://dx.doi.org/10.1097/FTD.0b013e31819476fa] [PMID: 19077929]
[15]
Cattaneo, D.; Baldelli, S.; Conti, F.; Cozzi, V.; Clementi, E. Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection. Ther. Drug Monit., 2010, 32(4), 520-524.
[http://dx.doi.org/10.1097/FTD.0b013e3181d5eeee] [PMID: 20300050]
[16]
Hara, S.; Uchiyama, M.; Yoshinari, M.; Matsumoto, T.; Jimi, S.; Togawa, A.; Takata, T.; Takamatsu, Y. A simple high-performance liquid chromatography for the determination of linezolid in human plasma and saliva. Biomed. Chromatogr., 2015, 29(9), 1428-1431.
[http://dx.doi.org/10.1002/bmc.3441] [PMID: 25678451]
[17]
Helmy, S.A. Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers. Ther. Drug Monit., 2013, 35(6), 770-777.
[http://dx.doi.org/10.1097/FTD.0b013e318297b6b0] [PMID: 24061442]
[18]
Swoboda, S.; Ober, M.; Anagnostakos, K.; Geiss, H.K.; Weigand, M.A.; Hoppe-Tichy, T. A simple isocratic HPLC assay to determine linezolid concentrations in different biomatrices for in vivo and in vitro studies. Clin. Chem. Lab. Med., 2007, 45(8), 1019-1022.
[http://dx.doi.org/10.1515/CCLM.2007.247] [PMID: 17867991]
[19]
Fortuna, S.; De Pascale, G.; Ragazzoni, E.; Antonelli, M.; Navarra, P. Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage. Biomed. Chromatogr., 2013, 27(11), 1489-1496.
[http://dx.doi.org/10.1002/bmc.2947] [PMID: 23813438]
[20]
Mohapatra, S.; Annapurna, M.M.; Ravi Kumar, B.V.V.; Anwar, M.; Warsi, M.H.; Akhter, S. Validated stability indicating RP-HPLC method for the estimation of linezolid in a pharmaceutical dosage form. J. Liq. Chromatogr. Relat. Technol., 2011, 34(18), 2185-2195.
[http://dx.doi.org/10.1080/10826076.2011.585548]
[21]
Zander, J.; Maier, B.; Zoller, M.; Teupser, D.; Vogeser, M. Quantification of linezolid in serum by LC-MS/MS using semi-automated sample preparation and isotope dilution internal standardization. Clin. Chem. Lab. Med., 2014, 52(3), 381-389.
[http://dx.doi.org/10.1515/cclm-2013-0594] [PMID: 24158423]
[22]
Souza, E.; Felton, J.; Crass, R.L.; Hanaya, K.; Pai, M.P. Development of a sensitive LC-MS/MS method for quantification of linezolid and its primary metabolites in human serum. J. Pharm. Biomed. Anal., 2020, 178, 112968.
[http://dx.doi.org/10.1016/j.jpba.2019.112968] [PMID: 31727360]
[23]
Paal, M.; Zoller, M.; Schuster, C.; Vogeser, M.; Schütze, G. Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC-MS/MS method. J. Pharm. Biomed. Anal., 2018, 152, 102-110.
[http://dx.doi.org/10.1016/j.jpba.2018.01.031] [PMID: 29414000]
[24]
Kitahashi, T.; Furuta, I. Further method development for measurement of linezolid in human serum by MEKC. J. Pharm. Biomed. Anal., 2004, 35(3), 615-620.
[http://dx.doi.org/10.1016/j.jpba.2004.01.020] [PMID: 15137987]
[25]
Kitahashi, T.; Furuta, I. Method development for determining the antibacterial linezolid in human serum by micellar electrokinetic capillary chromatography. J. Pharm. Biomed. Anal., 2002, 30(4), 1411-1416.
[http://dx.doi.org/10.1016/S0731-7085(02)00475-2] [PMID: 12408933]
[26]
De Oliveira, C.L.C.G.; Salgado, H.R.N.; de Lourdes Leite Moraes, M. Stability-indicating capillary zone electrophoresis assay for the analysis of linezolid in tablets. Braz. J. Pharm. Sci., 2018, 54(4), 1-7.
[http://dx.doi.org/10.1590/s2175-97902018000417585]
[27]
Toutain, J.; Boselli, E.; Djabarouti, S.; Allaouchiche, B.; Xuereb, F.; Bernadou, J.M.; Ba, B.; Saux, M.C.; Breilh, D. Determination of linezolid in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2004, 813(1-2), 145-150.
[http://dx.doi.org/10.1016/j.jchromb.2004.09.030] [PMID: 15556527]
[28]
Ehrlich, M.; Trittler, R.; Daschner, F.D.; Kümmerer, K. A new and rapid method for monitoring the new oxazolidinone antibiotic linezolid in serum and urine by high performance liquid chromatography-integrated sample preparation. J. Chromatogr. B Biomed. Sci. Appl., 2001, 755(1-2), 373-377.
[http://dx.doi.org/10.1016/S0378-4347(01)00115-3] [PMID: 11393729]
[29]
Buerger, C.; Joukhadar, C.; Muller, M.; Kloft, C. Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2003, 796(1), 155-164.
[http://dx.doi.org/10.1016/j.jchromb.2003.08.019] [PMID: 14552826]
[30]
Boak, L.M.; Li, J.; Nation, R.L.; Rayner, C.R. High-performance liquid chromatographic method for simple and rapid determination of linezolid in human plasma. Biomed. Chromatogr., 2006, 20(8), 782-786.
[http://dx.doi.org/10.1002/bmc.597] [PMID: 16292746]
[31]
Guo, P.; Li, X.; Wang, J.; You, A. Study on the compatibility of cefotaxime with tinidazole in glucose injection. J. Pharm. Biomed. Anal., 2007, 43(5), 1849-1853.
[http://dx.doi.org/10.1016/j.jpba.2006.12.009] [PMID: 17336022]
[32]
Pragst, F.; Herzler, M.; Erxleben, B.T. Systematic toxicological analysis by high-performance liquid chromatography with diode array detection (HPLC-DAD). Clin. Chem. Lab. Med., 2004, 42(11), 1325-1340.
[http://dx.doi.org/10.1515/CCLM.2004.251] [PMID: 15576293]
[33]
Locatelli, M.; Tinari, N.; Grassadonia, A.; Tartaglia, A.; Macerola, D.; Piccolantonio, S.; Sperandio, E.; D’Ovidio, C.; Carradori, S.; Ulusoy, H.I.; Furton, K.G.; Kabir, A. FPSE-HPLC-DAD method for the quantification of anticancer drugs in human whole blood, plasma, and urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2018, 1095, 204-213.
[http://dx.doi.org/10.1016/j.jchromb.2018.07.042] [PMID: 30081349]
[34]
Zhang, A.; Sun, H.; Wang, X.; Jiao, G.; Yuan, Y.; Sun, W. Simultaneous in vivo RP-HPLC-DAD quantification of multiple-component and drug-drug interaction by pharmacokinetics, using 6,7-dimethylesculetin, geniposide and rhein as examples. Biomed. Chromatogr., 2012, 26(7), 844-850.
[http://dx.doi.org/10.1002/bmc.1739] [PMID: 22068685]
[35]
Cios, A.; Kuś, K.; Szymura-Oleksiak, J. Determination of linezolid in human serum by reversed-phase high-performance liquid chromatography with ultraviolet and diode array detection. Acta Pol. Pharm., 2013, 70(4), 631-641.
[PMID: 23923387]
[36]
Cavazos-Rocha, N.; Vera-Cabrera, L.; Welsh-Lozano, O.; Waksman-de-Torres, N.; de la Luz Salazar-Cavazos, M. Simultaneous determination and validation of antimicrobials in plasma and tissue of actinomycetoma by high-performance liquid chromatography with diode array and fluorescence detection. J. Pharm. Biomed. Anal., 2007, 43(5), 1775-1781.
[http://dx.doi.org/10.1016/j.jpba.2006.12.019] [PMID: 17289329]
[37]
Traunmüller, F.; Mauric, O.; Popovic, M.; Joukhadar, C. Rapid and sensitive determination of the antibiotic linezolid in low plasma volumes by high-performance liquid chromatography. J. Chromatogr. Sci., 2010, 48(5), 325-327.
[http://dx.doi.org/10.1093/chromsci/48.5.325] [PMID: 20515522]
[38]
Borner, K.; Borner, E.; Lode, H. Determination of linezolid in human serum and urine by high-performance liquid chromatography. Int. J. Antimicrob. Agents, 2001, 18(3), 253-258.
[http://dx.doi.org/10.1016/S0924-8579(01)00383-1] [PMID: 11673038]

Rights & Permissions Print Cite
Article Metrics
22
1
© 2024 Bentham Science Publishers | Privacy Policy